These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 23977938)

  • 1. Pseudomonas aeruginosa treatment and transmission reduction.
    Bowers DR; Tam VH
    Expert Rev Anti Infect Ther; 2013 Aug; 11(8):831-7. PubMed ID: 23977938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005.
    Dejsirilert S; Suankratay C; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N; Tantisiriwat W
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S68-75. PubMed ID: 21298847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
    Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
    J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questioning the paradigm: monotherapy vs combination antimicrobial therapy for treatment of Pseudomonas aeruginosa.
    DeRyke CA; Kuti JL; Nicolau DP
    Conn Med; 2005 May; 69(5):271-5. PubMed ID: 16114642
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
    Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital.
    Jung R; Fish DN; Obritsch MD; MacLaren R
    J Hosp Infect; 2004 Jun; 57(2):105-11. PubMed ID: 15183239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hospital infections caused by Pseudomonas aeruginosa. Significance in intensive therapy].
    Sidorenko SV; Gel'fand EB; Mamontova OA
    Anesteziol Reanimatol; 1999; (3):46-54. PubMed ID: 10458038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
    Rice LB
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S100-5. PubMed ID: 16894511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media.
    Jang CH; Park SY
    Clin Otolaryngol Allied Sci; 2004 Aug; 29(4):321-3. PubMed ID: 15270816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target.
    Smith RS; Iglewski BH
    J Clin Invest; 2003 Nov; 112(10):1460-5. PubMed ID: 14617745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections.
    Watine J; Charet JC; Bruel A; Bouilloux JP; Palliez J
    Pathol Biol (Paris); 1996 Feb; 44(2):125-31. PubMed ID: 8761597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
    Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
    Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of malignant (necrotising) otitis externa.
    Hollis S; Evans K
    J Laryngol Otol; 2011 Dec; 125(12):1212-7. PubMed ID: 22018203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and future of the aerosoltherapy in the treatment of cystic fibrosis patients infected by Pseudomonas aeruginosa].
    Rognon A; Curti C; Montana M; Terme T; Rathelot P; Vanelle P
    Therapie; 2011; 66(6):481-91. PubMed ID: 22186073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on antimicrobial resistance and the role of newer antimicrobial agents for
    Pragasam AK; Veeraraghavan B; Nalini E; Anandan S; Kaye KS
    Indian J Med Microbiol; 2018; 36(3):303-316. PubMed ID: 30429381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum.
    Traugott KA; Echevarria K; Maxwell P; Green K; Lewis JS
    Pharmacotherapy; 2011 Jun; 31(6):598-608. PubMed ID: 21923444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
    Zavascki AP
    Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
    [No Abstract]   [Full Text] [Related]  

  • 19. Outbreak of hot-foot syndrome - caused by Pseudomonas aeruginosa.
    Michl RK; Rusche T; Grimm S; Limpert E; Beck JF; Dost A
    Klin Padiatr; 2012 Jul; 224(4):252-5. PubMed ID: 22187332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin-resistant Pseudomonas keratitis.
    Garg P; Sharma S; Rao GN
    Ophthalmology; 1999 Jul; 106(7):1319-23. PubMed ID: 10406614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.